Skip to content

MiGo Tracker Remote Monitoring of Home Exercise After Stroke

MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06752707
Enrollment
50
Registered
2024-12-31
Start date
2025-06-11
Completion date
2026-08-31
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacute Stroke

Keywords

Remote Therapeutic Monitoring, Stroke, Home Exercise Therapy, MiGo Tracker

Brief summary

This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.

Interventions

DEVICEMiGo Tracker

Perform home exercise sessions while wearing MiGo Tracker device that logs exercise data.

Exercise following printed sheets or booklet

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Rancho Research Institute, Inc.
CollaboratorOTHER
Flint Rehabilitation Devices, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assessor blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Experienced one or more strokes less than one month (30 days) prior * Upper Extremity Fugl-Meyer Score \> 5 and \<= 55 out of 66 * Absence of moderate to severe pain (\<= 4 on the 10 point visual-analog pain scale)

Exclusion criteria

* age \<18 years old * Unable to follow 2-step commands * Other neurological diagnosis (e.g. Parkinson's Disease) * Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study

Design outcomes

Primary

MeasureTime frameDescription
Change in Upper Extremity Fugl-Meyer from BaselineBaseline and 3 months post strokeThe Fugl-Meyer Assessment - Upper Extremity (FMA-UE) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, sensation, balance, joint range of motion and joint pain in patients with post-stroke hemiplegia. A standardized assessment of arm impairment based on scores of 0-2 on 33 different tasks. Minimum value = 0, maximum value = 66, higher scores = better outcome

Secondary

MeasureTime frameDescription
Change in Action Research Arm Test from BaselineBaseline and 3 months post strokeThe Action Research Arm Test (ARAT) is a 19-item measure aimed at assessing functional performance of the upper extremity through observational means. The ARAT is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from: (3) Performs test normally (2) Completes test, but takes abnormally long or has great difficulty (1) Performs test partially (0) Can perform no part of test
Change in Box and Blocks from BaselineBaseline and 3 months post strokeThe Box and Block Test assesses unilateral gross manual dexterity. The test is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.
Change in Motor Activity Log from BaselineBaseline and 3 months post strokeThe MAL is a semi-structured interview to assess arm function. Individuals are asked to rate Quality of Movement (QOM) and Amount of Movement (AOM) during 30 daily functional tasks. Items scored on a 6-point ordinal scale. Scoring on Amount of Use Scale: 0) The weaker arm was not sued at all for that activity (never) 1) very rarely 2) rarely 3) half pre-stroke 4)3/4 pre-stroke 5) normal. Quality of Movement Scale: 0) The weaker arm was not used at all for that activity (never) 1) very poor 2) poor 3) fair 4) almost normal 5) normal
Change in Modified Ashworth Spasticity Scale from BaselineBaseline and 3 months post strokeMAS is an assessment that is used to measure the increase in muscle tone. MAS assigns a grade of spasticity from a 0-4 ordinal scale. The grade is assigned by moving a joint/muscle through a high velocity quick stretch. A score of 1 indicates no resistance, and 5 indicates rigidity.
Change in Visual Analog Pain Scale from BaselineBaseline and 3 months post strokeThe visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10cm line that represents a continuum between no pain and worst pain.

Countries

United States

Contacts

Primary ContactIan M Russell, PhD
irussell@flintrehab.com3392232676
Backup ContactDaniel Zondervan, PhD
dzondervan@flintrehab.com949-313-7322

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026